Health care at an inflection point: Managing rising complexity

Health care is entering a more structurally constrained phase of the evolving middle market. Capital is more expensive. Regulatory obligations continue to increase, and the historical separation between clinical priorities and financial performance is fading. For middle market health systems in particular, operational complexity is no longer an incidental condition to navigate around. It is becoming the defining variable for shaping where leaders invest, what they standardize and, increasingly, what they divest.

RSM’s research on business complexity helps explain why this inflection point matters. Since the global financial crisis of 2007−09, operational complexity has increased materially across the industry and sectors, but its effects are most visible in the capital allocation decision matrix. As the cost of capital rises, tolerance for complexity falls. Hurdle rates increase, payback periods lengthen and uncertainty around future free cash flow intensifies, making it harder for leadership teams to balance near-term performance with long-term investment.

In health care, these pressures are compounded. Fragmented payer structures, challenges integrating clinical and financial data, supply chain volatility, and persistent workforce constraints all amplify risk. For nonprofit systems, community benefit obligations add another layer—reshaping how enterprise value is defined, defended and communicated to boards, bondholders, regulators and the communities they serve.

What’s emerging is a fundamental shift in how success will be determined. Over the next decade, the health care providers best positioned to succeed will treat value optimization as a system for decision making rather than a financial exercise—and as a must-have in today’s increasingly constrained middle market environment.

Governing complexity through an enterprise value roadmap

As complexity intensifies across the health care marketplace, capital allocation increasingly demands enterprise wide discipline. RSM’s enterprise value roadmap provides a practical way to connect the outcomes leaders care most about—financial sustainability, mission preservation and long-term resilience—to the decisions that actually create value.

Trends reshaping health care complexity in the decade ahead

Health care providers are entering a phase of industry transition, one driven by the convergence and acceleration of multiple forces rather than a single defining disruption, including:

• Workforce shortages
• Rapid digital adoption
• Evolving care models
• Tighter capital
• Value-based reimbursement
• Consumerism
• Regulatory expansion

Together, these forces are redefining how providers deploy capital, redesign operating models and evaluate performance, particularly among regional and middle market organizations with limited margin for error.

Workforce shortages become structural constraints

Access, cost and workforce shortages remain among the most pressing challenges confronting health care organizations. An aging population with increasingly complex medical needs is driving demand at a time when providers face shortages across clinical and support roles. Rising labor costs, clinician burnout and a tight labor market continue to restrict capacity and increase operating expenses, directly pressuring margins and access to care, particularly in rural and underserved markets.

Importantly, these challenges are no longer cyclical. Even as technology adoption accelerates, workforce constraints remain a structural feature of the health care operating environment. Leaders are being forced to redesign care teams, ensure that work assignments use the full scope of each clinician’s license and rethink how care is delivered across sites and modalities.

Enterprise value implication

Labor is no longer a variable cost lever to be pulled episodically. It is a long-term constraint that must be explicitly modeled into enterprise value roadmaps through productivity, automation, care team redesign and site-of-care strategy.

AI, automation and data move from innovation to infrastructure

Artificial intelligence, automation and data-driven operations are rapidly transforming both clinical and administrative functions. Providers face growing pressure to modernize legacy systems, adopt digital tools and leverage advanced analytics to drive efficiency and improve decision making.

AI adoption is accelerating across clinical and administrative use cases, including ambient documentation, revenue cycle automation, prior authorization, care management and predictive analytics. Market estimates project that AI spending in the U.S. health care market will grow to $43.3 billion by 2030, from $8.65 billion in 2025, signaling sustained investment and scale.

While these tools offer meaningful opportunities to reduce administrative burden, enhance care coordination and support workforce productivity, they also introduce new complexity around governance, cybersecurity, interoperability, data quality and return on investment. Organizations that approach AI as a collection of point solutions risk increasing fragmentation rather than reducing it, an especially costly misstep for middle market providers.

Enterprise value implication

AI is best understood not as a stand-alone cost-cutting tool, but as a productivity and coordination layer that can expand effective workforce capacity, reduce revenue leakage and improve capital, provided health care providers anchor investment decisions in a focused set of high-impact, governance-backed use cases and redesign operating models around those use cases before scaling technology.

Capital allocation and site-of-care shifts reshape strategy

Financial constraints, reimbursement pressure and changing patient preferences are accelerating the shift of care away from traditional inpatient settings toward outpatient, ambulatory, home-based and virtual care models. At the same time, capital has become more expensive, forcing sharper trade-offs across facilities, technology modernization and service line investment.

Bloomberg research points to a steady rise in provider capital spending, increasing from $5.9 billion in 2021 to $7.6 billion in 2025, with outlays projected to reach $8.2 billion by 2027, a roughly 30% increase over the period.

Recent spending patterns underscore a broader shift: While overall capital investment continues to grow, large inpatient-centric expansion projects are increasingly giving way to targeted renovations, ambulatory development and technology-driven investments.

Enterprise value implication

Capital allocation discipline, not capital availability, will increasingly determine winners, particularly in the middle market. Leadership teams should adopt enterprise value roadmaps to compare and prioritize investments across very different risk profiles and return timelines—from ambulatory expansion to digital infrastructure to workforce stabilization—and allocate capital accordingly.

Value-based care increases accountability and integration demands

The continued evolution toward value-based care adds another layer of operational and strategic complexity. Health care providers are increasingly accountable for outcomes, quality and total cost of care across populations, requiring stronger care coordination, deeper data integration and tighter clinical-financial alignment.

Transitioning from fee-for-service to value-based models often requires significant organizational change, including investment in analytics, care management and risk infrastructure, while operating in an environment where adoption remains uneven across payers and geographies.

Enterprise value implication

As value-based models expand, providers should focus on building enterprise value through sustained population management rather than episodic volume alone. This shift elevates the importance of tighter integration across service lines, sites of care and data platforms to enable coordinated, longitudinal decision making.

Looking ahead

Health care leaders cannot eliminate complexity; it is increasingly a structural feature of the industry. What they can control is how intentionally and effectively they manage it. Key considerations include:

• Make intentional trade-offs. As constraints tighten, leaders must be explicit about where to simplify, where to standardize and where complexity is unavoidable, and align capital and resources accordingly.
• Apply consistent capital discipline. With less room for error, investment decisions must be governed as a portfolio, balancing risk, return and longterm resilience rather than reacting to nearterm pressure.
• Strengthen alignment across the enterprise. Sustainable performance will depend on tighter integration of clinical, operational and financial leadership as care models, technology and reimbursement continue to evolve.

Organizations that approach business complexity with discipline and intent will preserve strategic flexibility in an increasingly unforgiving environment.

Portions of this article were originally published on our website as part of The Real Economy: Industry Outlook-Health Care, Health care at an inflection point: Managing rising complexity.